StockData
Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc. (ATOS) stock

ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.90−0.03 (-1.55%)

Close on Nov 17, 2026Market cap $18.96MP/E –Yield –

Earnings

Atossa Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Jan 8, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.56
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Atossa Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Jan 8, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 10, 2026before the open––-$0.56Release
Q2 FY2026ended Jun 30, 2026Aug 7, 2026before the open–––Release
Q4 FY2025ended Dec 31, 2025Jan 9, 2026before the open–––Filing
Q3 FY2025ended Sep 30, 2025Nov 12, 2025before the open–––Release
Q2 FY2025ended Jun 30, 2025Aug 12, 2025before the open––-$0.07Release
Q1 FY2025ended Mar 31, 2025May 13, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Mar 25, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open–––Release
Q2 FY2024ended Jun 30, 2024Aug 12, 2024before the open––-$0.05Release
Q1 FY2024ended Mar 31, 2024May 13, 2024before the open––-$0.05Release
Q4 FY2023ended Dec 31, 2023Apr 1, 2024after the close–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Atossa Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Atossa Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Atossa Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. News
  4. Update
  5. Results
  6. Update
  7. News
  8. News
  9. Results
  10. Update
  11. News
  12. Results
  13. Results
  14. Results
  15. News

See a number that looks wrong?